The manufacturing facility makes commercial drugs and cancer therapies, Genentech told the news outlet. The biotech merged with Roche in 2009, and the soon-to-close South San Francisco plant is on the same campus as Roche's headquarters for pharmaceutical operations in the U.S., according to Genentech's site.